Kris V. Kowdley, MD
Elafibranor Significantly Improves Prognosis For Patients With PBC, Study Finds
Elafibranor is predicted to increase transplant-free survival and reduce mortality over 15 years in patients with ...
FEBRUARY 13, 2025
Expert Picks From the 2017 Liver Meeting: Part 1
For this installment of Expert Picks, we asked Kris V. Kowdley, MD, of Washington State University, in Pullman, for ...
FEBRUARY 16, 2018
Load more